
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1040 | 975 | 1095 | 1068 | 1658 | 1179 |
Fund Return | 4.04% | -2.52% | 9.54% | 2.22% | 10.65% | 1.66% |
Place in category | 47 | 60 | 44 | 78 | 54 | 79 |
% in Category | 39 | 40 | 32 | 63 | 49 | 91 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
VanEck International Investors GolA | 380.34M | 34.62 | 8.96 | 10.96 | ||
VanEck International Investors GolY | 353.32M | 34.66 | 9.29 | 11.29 | ||
VanEck Emerging Markets Y | 202.32M | 2.08 | -0.26 | 1.23 | ||
VanEck International Investors GolI | 147.3M | 13.50 | 10.11 | 7.64 | ||
VanEck Global Hard Assets Y | 110.41M | 3.60 | -1.62 | 0.77 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price New Era I | 1.29B | 4.88 | 3.37 | - | ||
Vanguard Materials Index Adm | 1.2B | 0.94 | 0.95 | 7.75 | ||
Dreyfus Natural Resources I | 795.58M | -4.39 | -0.59 | 7.90 | ||
T. Rowe Price New Era | 830.68M | 4.84 | 3.18 | 4.83 | ||
Fidelity Select Chemicals | 481.11M | -1.19 | -1.48 | 5.64 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell ADR | US7802593050 | 4.91 | 62.09 | +3.86% | |
Exxon Mobil | US30231G1022 | 4.66 | 103.14 | +3.21% | |
TotalEnergies SE | FR0000120271 | 3.04 | 48.67 | -1.72% | |
Corteva | US22052L1044 | 3.00 | 59.28 | +2.31% | |
JBS ON | BRJBSSACNOR8 | 2.94 | 41.33 | -0.63% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review